Rainbow Seed Fund | Team Investment Focus Criteria Partners Campuses Synthetic Biology FAQs Portfolio Case Studies Fund Manager Impact Economic Value Wider Benefits News Rainbow Seed Fund News Portfolio News Partner Campus News Blog Contact Find Us Team Investment Focus Criteria Partners Campuses Synthetic Biology FAQs Portfolio Case Studies Fund Manager Impact Economic Value Wider Benefits News Rainbow Seed Fund News Portfolio News Partner Campus News Blog Contact Find Us More Than Just Money Rainbow's experienced team works with scientists and entrepreneurs from the earliest stages to build great companies using patient capital. Q A with Oliver Sexton Oliver Sexton , MSc, is Midvens investment director and manager of Rainbow Seed Funds synthetic biology investments. Read Q A Case Study Synthace Synthace provides next-generation software and processes to exponentially improve productivity in bioscience, enabling people to better engineer biology for health, food, energy and manufacturing. View Case Study Blog Engineering a winner: Rainbow Seed Fund SynbiCITE create £200k competition Read More News Big Prize for Small Companies With Global Ambition in Engineering Biology SynbiCITE and Rainbow Seed Fund announce new £200k competition Read More Case Study Oxsensis Oxsensis is a pioneering new breed of highly accurate, highly stable optical sensors View Case Study Blog Nine Key Steps to Fight Antibiotic Resistance Fighting drug resistance Read More An Early-Stage Venture Capital Fund Building and Growing Technology Companies Stemming From The UKs Research Base The Rainbow Seed Fund is backed by the Department for Business, Innovation and Skills and the Funds partners are 9 publicly funded research bodies, including STFC, BBSRC, NERC and Dstl. The Fund is independently managed by venture capital specialist Midven. We help build companies from great science developed in laboratories, science and technology campuses and synthetic biology. We hold investments in some of the UKs most innovative companies, in areas as diverse as novel antibiotics, research into Alzheimers disease, green chemicals and airport security. Meet Our Team Investment experience combined with business growth expertise. Investment Focus Early investment to establish technology companies that stem out of research. Portfolio A diverse range of investments in 30 companies. Watch News and Updates Latest News Survey results reveal the long reach of NPL's calibration Customers utilising the measurement services of the Time, Quantum and Electromagnetics (TQEM) research group... read more missharwell.com missharwell.com has position rank in alexa is 0 and rank in google page rank... read more show more Latest Tweets Follow @RainbowSeedFund Tweets by @RainbowSeedFund show more Recent Investments Featured Exits Blog A Discussion with Rainbow Seed Funds Oliver Sexton Oliver Sexton, MSc, is Midvens investment director and manager of Rainbow Seed Funds synthetic... read more Engineering a winner: Rainbow Seed Fund SynbiCITE create £200k... Midvens Rainbow Seed Fund, along with SynbiCITE, a pioneering Innovation and Knowledge Centre (IKC),... read more show more Follow Us Looking for Investment? Team Investment Focus Criteria Partners Campuses Synthetic Biology FAQs Portfolio Case Studies Fund Manager Impact Economic Value Wider Benefits News Rainbow Seed Fund News Portfolio News Partner Campus News Blog Contact Find Us Get Updates want more? we'll get back to you as soon as possible. submit © Rainbow Seed Fund 2016. All Rights Reserved. Midven Limited is Authorised and Regulated in the UK by the Financial Conduct Authority FRN 148549. Registered in England and Wales. Company Number 2500898 Registered Address: Midven Limited, Cavendish House, 39-41 Waterloo Street, Birmingham, B2 5PP | terms and conditions | privacy policy | site map